Journal
CANCER LETTERS
Volume 497, Issue -, Pages 28-40Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2020.10.014
Keywords
FHA domain; p53 dependent; Ubiquitination; Translational modification; Somatic AGGF1 variants
Categories
Funding
- China National Natural Science Foundation [81630002, 31430047, 81902860]
- Hubei Province Natural Science Program Innovative Team grant [2017CFA014]
Ask authors/readers for more resources
AGGF1 acts as a tumor suppressor by regulating p53 inside tumor cells, inhibiting MDM2 function, and influencing various properties of p53 and transcription of related genes, thereby affecting the growth and apoptosis of tumor cells.
Angiogenesis factors are widely known to promote tumor growth by increasing tumor angiogenesis in the tumor microenvironment, however, little is known whether their intracellular function is involved in tumorigenesis. Here we show that AGGF1 acts as a tumor suppressor by regulating p53 when acting inside tumor cells. AGGF1 antagonizes MDM2 function to inhibit p53 ubiquitination, increases the acetylation, phosphorylation, stability and expression levels of p53, activates transcription of p53 target genes, and regulates cell proliferation, cell cycle, and apoptosis. AGGF1 also interacts with p53 through the FHA domain. Somatic AGGF1 variants in the FHA domain in human tumors, including p.Q467H, p.Y469 N, and p.N483T, inhibit AGGF1 activity on tumor suppression. These results identify a key role for AGGF1 in an AGGF1-MDM2-p53 signaling axis with important functions in tumor suppression, and uncover a novel trans-tumor-suppression mechanism dependent on p53. This study has potential implications in diagnosis and therapies of cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available